Selective Agenesis of Mesencephalic Dopaminergic Neurons in Nurr1-Deficient Mice

Nurr1, a member of the nuclear receptor superfamily of transcription factors, has been found to be essential for the development of ventral midbrain dopamine (DA)ergic neurons. To study the regional selectivity and phenotypic specificity of regulation by Nurr1 of the genesis of DAergic neurons, we examined DAergic, serotonin (5-HT)ergic, norepinephrine (NE)ergic, cholinergic, glutamate (GLU)ergic, and gamma-aminobutyric acid (GABA)ergic neurons in the brains of Nurr1-deficient mice by immunohistochemistry and biochemistry. We demonstrated that in homozygous Nurr1-deficient mice (Nurr1-/-), DAergic neurons were totally absent in substantia nigra and ventral tegmental area, but preserved in other regions including diencephalon and hypothalamus, olfactory bulb (OB). Levels of DA in Nurr1-/- mice were decreased by 98% in striatum (Str) and 65% in OB. NEergic neurons in locus ceruleus, 5-HTergic neurons in raphe nuclei, and cholinergic neurons in basal forebrain and other regions were not changed. A 30% reduction of NE was found in the Str of Nurr1-/- mice. The levels of GLU and GABA and the activity of choline acetyl transferase in the brains of Nurr1-/- mice were not significantly altered. Our results demonstrate a selective and specific deficit of DA and absence of DAergic neurons in the mesencephalic structures of Nurr1-deficient mice, which resembles the pattern similar to that seen in patients with Parkinson's disease (PD). This model may contribute to our understanding of the mechanisms influencing DAergic cell survival in PD.

[1]  F. Hefti,et al.  Promotion of central cholinergic and dopaminergic neuron differentiation by brain-derived neurotrophic factor but not neurotrophin 3. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[2]  K. Jellinger,et al.  Pathology of Parkinson's disease. Changes other than the nigrostriatal pathway. , 1991, Molecular and chemical neuropathology.

[3]  Langston Jw.  Epidemiology versus genetics in parkinson's disease: Progress in resolving an age-old debate , 1998 .

[4]  G Wolterink,et al.  A homeodomain gene Ptx3 has highly restricted brain expression in mesencephalic dopaminergic neurons. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[5]  I. Wickelgren,et al.  Getting the Brain's Attention , 1997, Science.

[6]  L. Olson,et al.  Cellular expression of the immediate early transcription factors Nurr1 and NGFI-B suggests a gene regulatory role in several brain regions including the nigrostriatal dopamine system. , 1996, Brain research. Molecular brain research.

[7]  B J Hoffer,et al.  Dopamine neuron agenesis in Nurr1-deficient mice. , 1997, Science.

[8]  Y. Ono,et al.  Characterization of the 5'-flanking region of the human brain-derived neurotrophic factor gene. , 1992, Biochemical and biophysical research communications.

[9]  J. Jankovic,et al.  Reduced Nurrl Expression Increases the Vulnerability of Mesencephalic Dopamine Neurons to MPTP‐Induced Injury , 1999, Journal of neurochemistry.

[10]  M. Palkovits,et al.  Dopamine Biosynthesis Is Selectively Abolished in Substantia Nigra/Ventral Tegmental Area but Not in Hypothalamic Neurons in Mice with Targeted Disruption of the Nurr1 Gene , 1998, Molecular and Cellular Neuroscience.

[11]  J. Milbrandt.  Nerve growth factor induces a gene homologous to the glucocorticoid receptor gene , 1988, Neuron.

[12]  E. Shapira.  Techniques in diagnostic human biochemical genetics , 1991 .

[13]  P. Jenner,et al.  Understanding cell death in parkinson's disease , 1998, Annals of neurology.

[14]  M. Smidt,et al.  Nurr1 is essential for the induction of the dopaminergic phenotype and the survival of ventral mesencephalic late dopaminergic precursor neurons. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[15]  S. Daniel,et al.  Olfactory dysfunction in Parkinson's disease. , 1997, Journal of neurology, neurosurgery, and psychiatry.

[16]  T. Gasser.  Genetics of parkinson's disease , 1998, Annals of neurology.

[17]  T. Perlmann,et al.  A novel pathway for vitamin A signaling mediated by RXR heterodimerization with NGFI-B and NURR1. , 1995, Genes & development.

[18]  S. Appel,et al.  Use of [3H]-GBR12935 to measure dopaminergic nerve terminal growth into the developing rat striatum. , 1992, Brain research. Developmental brain research.

[19]  A. McMahon,et al.  Induction of dopaminergic neuron phenotype in the midbrain by Sonic hedgehog protein , 1995, Nature Medicine.

[20]  F. Fonnum,et al.  A rapid radiochemical method for the determination of choline acetyltransferase , 1975, Journal of neurochemistry.

[21]  C. D. Stern,et al.  Handbook of Chemical Neuroanatomy Methods in Chemical Neuroanatomy. Edited by A. Bjorklund and T. Hokfelt. Elsevier, Amsterdam, 1983. Cloth bound, 548 pp. UK £140. (Volume 1 in the series). , 1986, Neurochemistry International.

[22]  S. Fahn,et al.  The oxidant stress hypothesis in Parkinson's disease: Evidence supporting it , 1992, Annals of neurology.

[23]  J. Lile,et al.  GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. , 1993, Science.

[24]  B. O’Malley,et al.  Identification of a new brain-specific transcription factor, NURR1. , 1992, Molecular endocrinology.